WO2016071876A1 - Method for preparing type i collagen and for preparing unidirectional and multidirectional scaffolds containing same - Google Patents

Method for preparing type i collagen and for preparing unidirectional and multidirectional scaffolds containing same Download PDF

Info

Publication number
WO2016071876A1
WO2016071876A1 PCT/IB2015/058583 IB2015058583W WO2016071876A1 WO 2016071876 A1 WO2016071876 A1 WO 2016071876A1 IB 2015058583 W IB2015058583 W IB 2015058583W WO 2016071876 A1 WO2016071876 A1 WO 2016071876A1
Authority
WO
WIPO (PCT)
Prior art keywords
collagen
until
suspension
hours
freeze
Prior art date
Application number
PCT/IB2015/058583
Other languages
Spanish (es)
French (fr)
Inventor
Martha Raquel FONTANILLA DUQUE
Edward Baudilio SUESCA QUINTERO
Ronald Andrés JIMÉNEZ CRUZ
Original Assignee
Universidad Nacional De Colombia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Nacional De Colombia filed Critical Universidad Nacional De Colombia
Publication of WO2016071876A1 publication Critical patent/WO2016071876A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Definitions

  • This application relates a process for the purification of type I collagen, as well as the obtaining collagen powder, collagen hydrogels and development of unidirectional supports and multidirectional from this one.
  • Collagen is the main component of connective tissue and the most abundant protein in the body; It has an important role in membership, Chemotaxis and cell differentiation. They have described 28 types of collagen that are grouped into Subfamilies according to their structure: Colágenos fibrillar (types I, II, III, V, XI, XXIV and XXVII), fibrillar related and associated collagen (types IX, XII, XIV, XVI, XIX, XX, XXI and XXII), filamentous reticulate forming collagens (type VI), collagen associated to the basement membrane (types IV, VII, XV and XVIII), short chain collagens (types VIII and X), transmembrane collagens (types XIII, XVII, XXIII and XXV) and other collagens (types XXVI and XVIII) (Ricard, 2011; Gordon and Hahn, 2010).
  • type I In the family of collagens, type I is the one with the greatest presence in connective tissues soft as the skin, oral mucosa and hard as the bone. This protein provides great resistance to the tension, promotes the adhesion and migration of numerous cell types including monocytes, neutrophils, keratinocytes and fibroblasts (Friess, 1998). In the healing process, collagen I gradually replace other types of collagen when the tissue is remodeled and the scar matures (Gordon and Hahn, 2010). Once secreted by the fibroblasts of the wound bed is crosslinked to form fibers that help in the organization of cells, in the contractile and tissue replacement processes that they occur during healing (Gelse et al, 2003).
  • Collagen I is the most widely used protein in the development of supports for tissue engineering (Kirubanandan & Sehgal, 2010; Sauerbier et al., 2006; Fumiko et al., 2004; Takashi et al., 2001), since for its biocompatibility, biodegradability and bioactivity can interact with the environment in which it placed to induce tissue regeneration (Williams, 2003).
  • the material acquires a combination of properties (size of particle, shape, surface area and morphology) that determine process qualities such as fluency, humidification, hydration and dispersion, which make it in a good alternative as material for formulation procedures and / or excipients, allowing an easy transformation to other forms of presentation: films, particles, suspensions, granules, matrices among others (Cape, Villa et al. 2008).
  • the powdered form of collagen allows a Easy storage process, due to the use of slightly bulky and light containers, in addition to not require special and expensive conditions of Storage as refrigeration.
  • unidirectional supports have been investigated in tissue regeneration that they have a structure oriented like: nerves peripherals (Xueyu et al., 2009; Chamberlain et al., 1998; Stokols & Tuszynski, 2004), spinal cord (Spilker et al., 2001), tendon (Louie et al., 1997; Liu., Et al, 2008), cornea (Wray & Orwin, 2009) and bone (Silva et al., 2006, Yunoki, et al., 2006).
  • Lyophilization of collagen suspensions It is the most used method in the elaboration of supports of this biomaterial.
  • the microstructure of the support after lyophilization is a replica of the ice crystal morphology that forms after be frozen, so the structure can be directly controlled by freezing (Schoof et al., 2000).
  • the present invention relates the procedures for the purification of type I collagen, collagen hydrogels, collagen powder, supports multidirectional collagen and collagen supports Unidirectional, comprising the following stages:
  • Sources of type I collagen are taken from animal connective tissue such as fascia, tendons or bone
  • Said source of collagen is prepared by eliminating adjacent tissues that are attached to it, it is cut into pieces that allow its treatment and wash with water
  • the material is degreased by washing Consecutive starting with constant low solvents dielectric (20) and ending with high solvents dielectric constant (80), for example with ethanol at concentrations higher than 70%, ether and / or purified water.
  • An acidic acid solution is performed acetic or hydrochloric until a pH between 2.5 and 3.2, at temperatures below 5 ° C and stirring permanent
  • the product obtained is liquefied and centrifuged and then the supernatant is recovered
  • a solution of a salt is added to the pellet that gives the solution an ionic potential equivalent to a 0.7M sodium chloride solution until reaching a conductivity of between 50 and 70 mS / cm, stir for 1 to 24 hours, centrifuge and recover again the pellet obtained
  • Type I collagen is obtained.
  • the conductivity is important as it allows you to control the ionic strength and the ratio of charges to which it is submitted the collagen suspension.
  • the present invention allows the initial salt concentration (controlled by conductivity) help re-precipitate collagen I and solubilize proteins pollutants
  • the final conductivity control ensures that the remaining salt content does not affect the cellular behavior, when cells are exposed to the isolated and purified material.
  • the collagen suspension is quantified (gravimetric method or HPLC) and adjusted with water deionized between 2-10% P / P.
  • Air bubbles are removed from the Vacuum film (6.7 to 133.3 Pa) for ten minutes.
  • the film formed is removed by a spatula type tool and is crushed (production by fracture) in a mortar (application of a mechanical force).
  • the powder obtained is subsequently ground (intermediate mill type - rotary disc cutter).
  • the powder mixture obtained is classified by size by screening technique.
  • the dust fraction Majority must have a size range between 1.00 and 0.30 mm equivalent to the fraction that passes through a sieve standard number 30 and retained by a standard sieve number 20.
  • Figure 1 shows a collagen support type I in whose processing has been applied, in some of the mold walls, a thermally conductive material inert with which unidirectional supports are achieved.
  • Figure 2 presents a collagen support type I in which the fibers are arranged in all directions during the freezing stage and it turns out forming a multidirectional support.
  • the tissue is dissolved with acid 0.5 M acetic acid and stirring at cooling temperature for a space of 24 hours
  • the product is liquefied and centrifuged
  • NaCl pellet is added until a conductivity: 50-70 mS / cm
  • Collagen powder preparation preparation:
  • the collagen suspension is quantified (gravimetric method or HPLC) and adjusted with water deionized at a percentage between 1-10% P / P.
  • a film is served on Teflon molds homogeneous of the collagen suspension.
  • the film formed is crushed.
  • the powder obtained is subsequently ground (intermediate mill type - rotary disc cutter).
  • the powder mixture obtained is classified by sizes by sieving technique.
  • the fraction of Majority powders should have a size range between 1.00 and 0.30 mm.

Abstract

The invention hereby claimed relates to the field of tissue engineering and concerns a method for isolating type I collagen from rat tail and producing multidirectional scaffolds (Pérez et al., 2001). In recent years, the isolating method has been modified and standardised. Likewise, changes have been introduced into the method for obtaining scaffolds from this collagen and a novel method has been developed for producing unidirectional laminar scaffolds. In the optimised method, the animal collagen source is cleaned, cut and suspended in an acetic acid solution until a liquid phase pH between 2.5 and 3.2 is reached, agitating constantly at 4°C. Said suspension is centrifuged and the pH of the supernatant obtained is neutralised with NaOH in order to re-separate the solid and liquid phases. The collagen precipitated in this way is re-precipitated with salts and solubised in acetic acid, and the solution is poured into moulds, frozen at -20°C and freeze-dried. Lastly, the scaffolds obtained are cross-linked and then sterilised with ethylene oxide.

Description

PROCEDIMIENTO PARA LA PREPARACIÓN DE COLÁGENO TIPO 1 Y DE SOPORTES UNIDIRECCIONALES Y MULTIDIRECCIONALES QUE LO CONTIENENCOLLAGEN PREPARATION PROCEDURE             TYPE 1 AND UNIDIRECTIONAL AND MULTIDIRECTIONAL SUPPORTS             THAT CONTAIN IT
La presente solicitud relaciona un proceso para la purificación de colágeno tipo I, así como la obtención de colágeno en polvo, hidrogeles de colágeno y elaboración de soportes unidireccionales y multidireccionales a partir de éste.This application relates a process                 for the purification of type I collagen, as well as the                 obtaining collagen powder, collagen hydrogels and                 development of unidirectional supports and                 multidirectional from this one.
Colágeno en ingeniería de tejidos:Collagen in tissue engineering:
El colágeno es el principal componente del tejido conectivo y la proteína más abundante en el cuerpo humano; tiene un papel importante en la adhesión, quimiotaxis y en la diferenciación celular. Se han descrito 28 tipos de colágeno que se agrupan en subfamilias de acuerdo a su estructura: Colágenos fibrilares (tipos I, II, III, V, XI, XXIV y XXVII), colágenos relacionados y asociados a los fibrilares (tipos IX, XII, XIV, XVI, XIX, XX, XXI y XXII), colágenos formadores de reticulados filamentosos (tipo VI), colágenos asociados a la membrana basal (tipos IV, VII, XV y XVIII), colágenos de cadena corta (tipos VIII y X), colágenos transmembranales (tipos XIII, XVII, XXIII y XXV) y otros colágenos (tipos XXVI y XXVIII) (Ricard, 2011; Gordon and Hahn, 2010).Collagen is the main component of                 connective tissue and the most abundant protein in the                 body; It has an important role in membership,                 Chemotaxis and cell differentiation. They have                 described 28 types of collagen that are grouped into                 Subfamilies according to their structure: Colágenos                 fibrillar (types I, II, III, V, XI, XXIV and XXVII),                 fibrillar related and associated collagen                 (types IX, XII, XIV, XVI, XIX, XX, XXI and XXII),                 filamentous reticulate forming collagens (type                 VI), collagen associated to the basement membrane (types IV,                 VII, XV and XVIII), short chain collagens (types VIII                 and X), transmembrane collagens (types XIII, XVII,                 XXIII and XXV) and other collagens (types XXVI and XXVIII)                 (Ricard, 2011; Gordon and Hahn, 2010).
En la familia de los colágenos, el tipo I es el que mayor presencia tiene en tejidos conectivos blandos como la piel, la mucosa oral y en duros como el hueso. Esta proteína proporciona una gran resistencia a la tensión, promueve la adhesión y migración de numerosos tipos celulares incluyendo monocitos, neutrófilos, queratinocitos y fibroblastos (Friess, 1998). En el proceso de cicatrización, el colágeno I reemplaza gradualmente otros tipos de colágeno cuando el tejido es remodelado y la cicatriz madura (Gordon and Hahn, 2010). Una vez secretado por los fibroblastos del lecho de la herida es entrecruzado para formar fibras que ayudan en la organización de las células, en los procesos contráctiles y de recambio de tejido que ocurren durante la cicatrización (Gelse et al, 2003). In the family of collagens, type I is                 the one with the greatest presence in connective tissues                 soft as the skin, oral mucosa and hard as the                 bone. This protein provides great resistance to                 the tension, promotes the adhesion and migration of                 numerous cell types including monocytes,                 neutrophils, keratinocytes and fibroblasts (Friess,                 1998). In the healing process, collagen I                 gradually replace other types of collagen when the                 tissue is remodeled and the scar matures (Gordon and                 Hahn, 2010). Once secreted by the fibroblasts of the                 wound bed is crosslinked to form fibers                 that help in the organization of cells, in the                 contractile and tissue replacement processes that                 they occur during healing (Gelse et al, 2003).
El colágeno I es la proteína más empleada en la elaboración de soportes para ingeniería de tejidos (Kirubanandan & Sehgal, 2010; Sauerbier et al., 2006; Fumiko et al., 2004; Takashi et al., 2001), ya que por su biocompatibilidad, biodegradabilidad y bioactividad puede interactuar con el ambiente en que se coloca para inducir regeneración de los tejidos (Williams, 2003).Collagen I is the most widely used protein in                 the development of supports for tissue engineering                 (Kirubanandan & Sehgal, 2010; Sauerbier et al.,                 2006; Fumiko et al., 2004; Takashi et al., 2001), since                 for its biocompatibility, biodegradability and                 bioactivity can interact with the environment in which it                 placed to induce tissue regeneration                 (Williams, 2003).
La forma de presentación más común del colágeno es en estado sólido, ya que permite aumentar su tiempo de vida media, debido a que se disminuye la movilidad molecular, reduciendo la velocidad de las reacciones de degradación (hidrólisis, oxidación, deaminación, racemización, etc.) (Manning, Chou et al. 2010), además de poseer una baja actividad de agua, factor que disminuye las probabilidades de contaminación y degradación microbiológica del colágeno (Miyawaki 2009). Al obtener el colágeno en forma de polvo, el material adquiere una combinación de propiedades (tamaño de partícula, forma, área superficial y morfología) que determinan cualidades de proceso como fluidez, humectación, hidratación y dispersión, que lo convierten en una buena alternativa como material para procedimientos y/o excipientes de formulación, permitiendo una fácil transformación a otras formas de presentación: películas, partículas, suspensiones, gránulos, matrices entre otros (Cape, Villa et al. 2008). Además, la forma en polvo del colágeno permite un proceso de almacenamiento fácil, debido al uso de recipientes poco voluminosos y livianos, además de no requerir condiciones especiales y costosas de almacenamiento como la refrigeración.The most common form of presentation of                 collagen is in solid state, since it allows to increase its                 half-life, because the                 molecular mobility, reducing the speed of                 degradation reactions (hydrolysis, oxidation,                 deamination, racemization, etc.) (Manning, Chou et al.                 2010), in addition to having a low water activity,                 factor that decreases the likelihood of contamination                 and microbiological degradation of collagen (Miyawaki                 2009). By obtaining the collagen in powder form, the                 material acquires a combination of properties (size                 of particle, shape, surface area and morphology) that                 determine process qualities such as fluency,                 humidification, hydration and dispersion, which make it                 in a good alternative as material for                 formulation procedures and / or excipients,                 allowing an easy transformation to other forms of                 presentation: films, particles, suspensions,                 granules, matrices among others (Cape, Villa et al.                 2008). In addition, the powdered form of collagen allows a                 Easy storage process, due to the use of                 slightly bulky and light containers, in addition to not                 require special and expensive conditions of                 Storage as refrigeration.
Entre los procesos más comunes para la elaboración de polvos se encuentran la liofilización, el secado por aspersión y el uso de fluidos supercríticos (Cape, Villa et al. 2008), metodologías que requieren equipos robustos, lo que hace que estos procesos sean costosos. Una alternativa más económica es el uso de secado por convección forzada de aire, que permite controlar los procesos de transferencia de calor y masa, sin alterar la calidad del producto (Paul Malumba, 2008), sin embargo, este proceso no se ha empleado en el secado de colágeno.Among the most common processes for                 Powder processing are freeze drying, the                 spray drying and the use of supercritical fluids                 (Cape, Villa et al. 2008), methodologies that require                 robust equipment, which makes these processes                 expensive. A cheaper alternative is the use of                 forced air convection drying, which allows                 control the processes of heat and mass transfer,                 without altering the quality of the product (Paul Malumba,                 2008), however, this process has not been used in the                 collagen drying
Soportes en la ingeniería de tejidos:Tissue engineering supports:
Uno de los mayores desafíos de la ingeniería de tejidos es reproducir la compleja organización celular y restablecer las funciones que las células cumplen en el tejido nativo del cuerpo humano (Griffith & Swartz, 2006). La estructura de un tejido y su función están altamente relacionadas. En el tendón las fibras están ordenadas de manera unidireccional, lo que le proporciona su alta resistencia a la tensión (Kuo et al., 2010); el patrón de fibras al azar del colágeno en la piel le da sus propiedades mecánicas (Bottcher et al., 2010); la forma de copa de los alveolos pulmonares da eficiencia al proceso de intercambio gaseoso (Chen et al., 2005; Faraj et al., 2007) y el arreglo complejo y poligonal de los hepatocitos es esencial para la apropiada función hepática (Tsang & Bhatia, 2006). Para imitar esta organización los soportes empleados en ingeniería de tejidos son modificados en su microestructura, la cual se define por la porosidad, interconectividad, tamaño y dirección de los poros.One of the greatest engineering challenges                 of tissues is to reproduce the complex organization                 cell and restore functions that cells                 meet in the native tissue of the human body (Griffith                 & Swartz, 2006). The structure of a fabric and its                 Function are highly related. In the tendon the                 fibers are arranged unidirectionally, which                 provides you with high tensile strength (Kuo et                 al., 2010); the random fiber pattern of collagen in                 the skin gives it its mechanical properties (Bottcher et                 al., 2010); the cup shape of the pulmonary alveoli                 gives efficiency to the gas exchange process (Chen et                 al., 2005; Faraj et al., 2007) and the complex arrangement and                 Polygonal hepatocyte is essential for the                 appropriate liver function (Tsang & Bhatia, 2006).                 To imitate this organization the supports used in                 tissue engineering are modified in their                 microstructure, which is defined by porosity,                 interconnectivity, size and direction of the pores.
La fabricación de soportes unidireccionales ha sido investigada en la regeneración de tejidos que presentan una estructura orientada como: nervios periféricos (Xueyu et al., 2009; Chamberlain et al., 1998; Stokols & Tuszynski, 2004), medula espinal (Spilker et al., 2001), tendón (Louie et al., 1997; Liu., et al, 2008), cornea (Wray & Orwin, 2009) y hueso (Silva et al., 2006, Yunoki, et al., 2006). Estudios in vivo en animales han demostrado que soportes para regeneración nerviosa con microcanales unidireccionales orientados longitudinalmente permiten alcanzar una regeneración y recuperación funcional equivalente al auto injerto, sin el uso de agentes regenerativos externos o células (Xueyu et al., 2009; Yannas, 2005). Otro estudio mostró que la microestructura afecta el fenotipo de fibroblastos corneales, ya que las fibras de colágeno alineadas actúan como un mecanismo de señalización para disminuir la expresión de alfa-actina en fibroblastos corneales de conejo (Wray & Orwin, 2009). The manufacture of unidirectional supports has                 been investigated in tissue regeneration that                 they have a structure oriented like: nerves                 peripherals (Xueyu et al., 2009; Chamberlain et al.,                 1998; Stokols & Tuszynski, 2004), spinal cord                 (Spilker et al., 2001), tendon (Louie et al., 1997;                 Liu., Et al, 2008), cornea (Wray & Orwin, 2009) and                 bone (Silva et al., 2006, Yunoki, et al., 2006).                 In vivo studies in animals have shown that supports                 for nerve regeneration with microchannels                 Unidirectional oriented longitudinally allow                 achieve functional regeneration and recovery                 equivalent to self grafting, without the use of agents                 external regenerative or cells (Xueyu et al., 2009;                 Yannas, 2005). Another study showed that the                 microstructure affects the fibroblast phenotype                 corneal, since the collagen fibers aligned                 they act as a signaling mechanism to decrease                 alpha-actin expression in corneal fibroblasts of                 rabbit (Wray & Orwin, 2009).
Para desarrollar estos soportes se han empleado métodos de fabricación con técnicas de separación de fases (Ma & Zhang, 2001), fabricación de sólidos con formas libres (Taboas et al., 2003), prototipado rápido (Wilson et al., 2004) y congelamiento unidireccional (Madaghiele et al., 2007), sin embargo, estos métodos producen soportes de dimensiones pequeñas (aproximadamente 3mm x 5mm), además requieren de equipamiento complejo y costoso.To develop these supports have                 employed manufacturing methods with techniques of                 phase separation (Ma & Zhang, 2001), manufacturing                 of solids with free forms (Taboas et al., 2003),                 rapid prototyping (Wilson et al., 2004) and freezing                 unidirectional (Madaghiele et al., 2007), however,                 these methods produce supports of small dimensions                 (approximately 3mm x 5mm), also require                 complex and expensive equipment.
La liofilización de suspensiones de colágeno es el método más empleado en la elaboración de soportes de este biomaterial. La microestructura del soporte después de la liofilización es una réplica de la morfología del cristal de hielo que se forma después de ser congelado, por lo que la estructura puede ser controlada directamente por el congelamiento (Schoof et al., 2000).Lyophilization of collagen suspensions                 It is the most used method in the elaboration of supports                 of this biomaterial. The microstructure of the support                 after lyophilization is a replica of the                 ice crystal morphology that forms after                 be frozen, so the structure can be                 directly controlled by freezing (Schoof et                 al., 2000).
Dada la importancia que conlleva la obtención de soportes de colágeno tipo I, el desarrollo de este proceso optimizado aquí reivindicado, muestra la conveniencia de establecer procesos mejorados que además de superar las desventajas presentes en los procesos existentes permitan la obtención de soportes de colágeno I con características superiores a las existentes.Given the importance of obtaining                 of type I collagen supports, the development of this                 optimized process claimed here, shows the                 convenience of establishing improved processes that also                 of overcoming the disadvantages present in the processes                 existing allow the obtaining of collagen supports                 I with characteristics superior to the existing ones.
La presente invención relaciona los procedimientos para la purificación de colágeno tipo I, hidrogeles de colágeno, colágeno en polvo, soportes de colágeno multidireccionales y soportes de colágeno unidireccionales, que comprenden las siguientes etapas:The present invention relates the                 procedures for the purification of type I collagen,                 collagen hydrogels, collagen powder, supports                 multidirectional collagen and collagen supports                 Unidirectional, comprising the following stages:
1. Purificación de colágeno tipo I.1. Purification of type I collagen.
Se toman fuentes de colágeno tipo I provenientes de tejido conectivo animal como fascia, tendones o hueso.Sources of type I collagen are taken                 from animal connective tissue such as fascia,                 tendons or bone
Dicha fuente de colágeno se prepara eliminando tejidos adyacentes que se encuentren adheridos a ella, se corta en trozos que permitan su tratamiento y se lavan con aguaSaid source of collagen is prepared by eliminating                 adjacent tissues that are attached to it,                 it is cut into pieces that allow its treatment and                 wash with water
El material se desengrasa mediante lavados consecutivos empezando con solventes de baja constante dieléctrica (20) y finalizando con solventes de alta constante dieléctrica (80), por ejemplo con etanol a concentraciones superiores a 70%, éter y/o agua purificada.The material is degreased by washing                 Consecutive starting with constant low solvents                 dielectric (20) and ending with high solvents                 dielectric constant (80), for example with ethanol at                 concentrations higher than 70%, ether and / or purified water.
Se realiza una disolución ácida con ácido acético o clorhídrico hasta lograr un pH entre 2,5 y 3,2, a temperaturas inferiores a 5 °C y agitación permanente An acidic acid solution is performed                 acetic or hydrochloric until a pH between 2.5 and                 3.2, at temperatures below 5 ° C and stirring                 permanent
Se licua y centrifuga el producto obtenido y luego se recupera el sobrenadanteThe product obtained is liquefied and centrifuged and                 then the supernatant is recovered
Se adiciona al sobrenadante un álcali como NaOH o KOH hasta lograr un pH entre 4,0 y 5.0; luego se centrifuga y recupera el pellet obtenidoAn alkali is added to the supernatant as                 NaOH or KOH until a pH between 4.0 and 5.0 is achieved; then I know                 centrifuge and recover the pellet obtained
Se adiciona al pellet una solución de una sal que le otorgue a la solución un potencial iónico equivalente al de una solución de cloruro de sodio 0,7M hasta alcanzar una conductividad de entre 50 y 70 mS/cm, se agita entre 1 y 24 horas, se centrifuga y recupera nuevamente el pellet obtenidoA solution of a salt is added to the pellet                 that gives the solution an ionic potential                 equivalent to a 0.7M sodium chloride solution                 until reaching a conductivity of between 50 and 70 mS / cm,                 stir for 1 to 24 hours, centrifuge and recover                 again the pellet obtained
Se realizan sucesivos lavados con agua a temperaturas inferiores a 5 °C y agitación, se centrifuga y recupera el pellet; todo esto se repite hasta lograr una conductividad en el agua de lavado entre 200 y 500 µS/cmSuccessive water washes are performed at                 temperatures below 5 ° C and stirring,                 centrifuge and recover the pellet; all this repeats                 until a conductivity in the wash water is achieved                 between 200 and 500 µS / cm
Se obtiene colágeno Tipo I.Type I collagen is obtained.
En la presente invención, se determinó que la conductividad es importante ya que permite controlar la fuerza iónica y la relación de cargas a la que es sometida la suspensión de colágeno. La presente invención permite que la concentración de sal inicial (controlada mediante la conductividad) ayude a re-precipitar el colágeno I y a solubilizar proteínas contaminantes. El control de la conductividad final asegura que el contenido de sal remanente no afecte el comportamiento celular, cuando las células son expuestas al material aislado y purificado.In the present invention, it was determined that the                 conductivity is important as it allows you to control the                 ionic strength and the ratio of charges to which it is                 submitted the collagen suspension. The present                 invention allows the initial salt concentration                 (controlled by conductivity) help                 re-precipitate collagen I and solubilize proteins                 pollutants The final conductivity control                 ensures that the remaining salt content does not affect the                 cellular behavior, when cells are exposed                 to the isolated and purified material.
2. Preparación de colágeno en polvo:2. Preparation of collagen powder:
Se cuantifica la suspensión de colágeno (método gravimétrico o HPLC) y se ajusta con agua desionizada entre 2-10% P/P.The collagen suspension is quantified                 (gravimetric method or HPLC) and adjusted with water                 deionized between 2-10% P / P.
Sobre moldes de teflón, se sirve una película homogénea de la suspensión de colágeno de un espesor deseado (entre 3 y 8 mm).On Teflon molds, a film is served                 homogeneous of a thick collagen suspension                 desired (between 3 and 8 mm).
Se eliminan las burbujas de aire de la película mediante vacio (6,7 a 133.3 Pa) por diez minutos.Air bubbles are removed from the                 Vacuum film (6.7 to 133.3 Pa) for ten minutes.
Se seca por convección forzada de aire a un flujo de aire constante entre 20m3/hora a 40 m3/hora y a una temperatura de 55 ± 5 °C por 48 horasIt is dried by forced air convection at a                 constant air flow between 20m3 / hour at 40 m3 / hour and                 at a temperature of 55 ± 5 ° C for 48 hours
La película formada es retirada mediante una herramienta tipo espátula y se tritura (producción por fractura) en un mortero (aplicación de una fuerza mecánica).The film formed is removed by a                 spatula type tool and is crushed (production by                 fracture) in a mortar (application of a mechanical force).
El polvo obtenido es posteriormente molido (tipo molino intermedio - cortador de disco rotatorio). La mezcla de polvos obtenida es clasificada por tamaños mediante la técnica de tamizado. La fracción de polvos mayoritaria debe tener una rango de tamaño entre 1.00 y 0,30 mm equivalente a la fracción que pasa por un tamiz estándar número 30 y retenido por un tamiz estándar número 20.The powder obtained is subsequently ground                 (intermediate mill type - rotary disc cutter).                 The powder mixture obtained is classified by size                 by screening technique. The dust fraction                 Majority must have a size range between 1.00 and                 0.30 mm equivalent to the fraction that passes through a sieve                 standard number 30 and retained by a standard sieve                 number 20.
3. Obtención de hidrogel de colágeno 3. Obtaining collagen hydrogel
Pesar entre 1 y 10 g de Colágeno I en polvoWeigh between 1 and 10 g of Collagen I powder
Adicionar entre 100 y1000 mL de acido acético 0,5N de acuerdo a la concentración de colágeno deseada.Add between 100 and 1000 mL of acetic acid                 0.5N according to the desired collagen concentration.
Homogeneizar en un homogenizador de rotor estator a una velocidad entre 3000 y 8000 rpm.Homogenize in a rotor homogenizer                 stator at a speed between 3000 and 8000 rpm.
Hidratar por un tiempo entre 12 y 18 horas Hydrate for a time between 12 and 18 hours
Adicionar ácido acético 0,5 N hasta para lograr la concentración deseadaAdd 0.5 N acetic acid until                 achieve the desired concentration
Homogeneizar en un homogenizador de rotor estator a una velocidad entre 3000 y 8000 rpmHomogenize in a rotor homogenizer                 stator at a speed between 3000 and 8000 rpm
Centrifugar por 15 minutos a una velocidad entre 3000 y 8000 rpm.Centrifuge for 15 minutes at a speed                 between 3000 and 8000 rpm.
Desechar sobrenadante.Discard supernatant.
Cuantificar el pellet formado.Quantify the pellet formed.
Ajustar la suspensión a la concentración deseada (entre 1 y 10 % p/p de colágeno), con ácido acético 0,5 NAdjust the suspension to the concentration                 desired (between 1 and 10% w / w collagen), with acid                 acetic 0.5 N
Mantener almacenado a 4°C.Keep stored at 4 ° C.
4. Obtención de soportes de colágeno4. Obtaining collagen supports
La suspensión obtenida se coloca en moldes de material químicamente inerte y antiadherente como teflón. Posteriormente se deben realizar los siguientes procedimientos:The suspension obtained is placed in molds of                 chemically inert and nonstick material such as                 Teflon Subsequently, the following procedures must be performed:
Desgasificar la suspensión aplicando vacío.Degassing the suspension by applying vacuum.
Congelar la suspensión a una temperatura entre -20 a -40°C para obtener soportes multidireccionales. Para elaborar soportes unidireccionales se cubre una de las paredes del molde con un material termoconductor inerte y se pone en contacto parte de este con un agente de congelamiento adecuado asegurando un gradiente de temperatura de 20 a 60°C a través de la suspensión.Freeze the suspension at a temperature between                 -20 to -40 ° C to obtain multidirectional supports.                 To make unidirectional supports one of                 the walls of the mold with a thermally conductive material                 inert and part of it is contacted with an agent                 adequate freezing ensuring a gradient of                 temperature of 20 to 60 ° C through the suspension.
Liofilizar con el fin de producir una estructura porosa interconectadaFreeze dry in order to produce a                 interconnected porous structure
Sumergir el material liofilizado en una solución acuosa con un agente de reticulación (genipina, glutaraldehido, dendrímeros, carbodiimidas o una mezcla de ellos)Dip the lyophilized material in a                 aqueous solution with a crosslinking agent (genipin,                 glutaraldehyde, dendrimers, carbodiimides or a mixture                 from them)
Desgasificar el sistemaDegassing the system
Dejar reaccionar entre 24 y 48 horasLeave to react for 24 to 48 hours
Retirar la solución que contiene el agente de reticulaciónRemove the solution containing the crosslinking agent
Hacer lavados con agua hasta garantizar el retiro del agente de reticulaciónWash with water until the                 removal of the crosslinking agent
Congelar el soporte entrecruzadoFreeze crosslinked support
LiofilizarFreeze dry
Esterilizar mediante oxido de etileno, radiación gamma o etanol 70%Sterilize by ethylene oxide,                 70% gamma or ethanol radiation
Si se toma la opción de las paredes recubiertas con el material conductor, se logra un soporte unidireccional (Figura 1); en caso de no usarse se logra un soporte multidireccional (Figura 2).If you take the option of the walls                 coated with the conductive material, a                 unidirectional support (Figure 1); if not used                 multidirectional support is achieved (Figure 2).
Las Figuras que acompañan esta descripción presentan dos fotografías de imágenes de microscopía electrónica de barrido sobre soportes de colágeno obtenidos por la tecnología aquí reivindicada.The figures that accompany this description                 present two photographs of microscopy images                 scanning electronics on collagen supports                 obtained by the technology claimed here.
La Figura 1 muestra un soporte de colágeno tipo I en cuyo procesamiento se ha aplicado, en alguna de las paredes del molde, un material termoconductor inerte con lo cual se logran soportes unidireccionales.Figure 1 shows a collagen support                 type I in whose processing has been applied, in some                 of the mold walls, a thermally conductive material                 inert with which unidirectional supports are achieved.
La Figura 2 presenta un soporte de colágeno tipo I en el cual las fibras se disponen en todas las direcciones durante la etapa de congelación y resulta conformando un soporte multidireccionales.Figure 2 presents a collagen support                 type I in which the fibers are arranged in all                 directions during the freezing stage and it turns out                 forming a multidirectional support.
Maneras de realizar la invenciónWays to realize the invention
Se encontró un protocolo preferido para la producción de colágeno tipo 1 con las siguientes secuencias:A preferred protocol was found for                 Type 1 collagen production with the following sequences:
Se parte de fragmentos de fascia o tendones de rata, bovinos o porcinosIt starts from fragments of fascia or tendons of                 rat, cattle or pigs
Se hacen lavados con diferentes solventes o mezclas de solventes que permitan obtener constantes dieléctricas en un intervalo entre 10 y 80.They are washed with different solvents or                 solvent mixtures that allow obtaining constants                 dielectrics in a range between 10 and 80.
Se hace la disolución del tejido con ácido acético 0,5 M y agitación a temperatura de refrigeración por un espacio de 24 horasThe tissue is dissolved with acid                 0.5 M acetic acid and stirring at cooling temperature                 for a space of 24 hours
Se licua y centrifuga el producto The product is liquefied and centrifuged
Se recupera el sobrenadanteThe supernatant is recovered
Se adiciona al sobrenadante NaOH 2M2M NaOH supernatant is added
Se centrifuga a 5000 rpm por 15 min y se recupera el pelletIt is centrifuged at 5000 rpm for 15 min and                 recover the pellet
Se lava con un volumen de agua igual al volumen de pellet obtenidoWash with a volume of water equal to                 volume of pellet obtained
Se centrifuga a 5000 rpm por 15 min y se recupera el pelletIt is centrifuged at 5000 rpm for 15 min and                 recover the pellet
Se adiciona al pellet NaCl hasta lograr una conductividad: 50-70 mS/cmNaCl pellet is added until a                 conductivity: 50-70 mS / cm
Se agita a 60 rpm por 1 horaStir at 60 rpm for 1 hour.
Se centrifuga y se recupera el pelletIt is centrifuged and the pellet is recovered
Se repiten la adición de agua, centrifugación y recuperación del precipitado hasta que las aguas de lavado alcancen una conductividad entre 200-500 mS/cmWater addition repeated, centrifugation                 and recovery of the precipitate until the waters of                 washing reach a conductivity between 200-500 mS / cm
Preparación de colágeno en polvo:Collagen powder preparation:
Se cuantifica la suspensión de colágeno (método gravimétrico o HPLC) y se ajusta con agua desionizada a un porcentaje entre 1-10% P/P.The collagen suspension is quantified                 (gravimetric method or HPLC) and adjusted with water                 deionized at a percentage between 1-10% P / P.
Se sirve sobre moldes de teflón una película homogénea de la suspensión de colágeno.A film is served on Teflon molds                 homogeneous of the collagen suspension.
Se eliminan las burbujas de aire de la película mediante vacioAir bubbles are removed from the                 empty film
Se seca.It dries up.
La película formada se tritura.The film formed is crushed.
El polvo obtenido es posteriormente molido (tipo molino intermedio - cortador de disco rotatorio). La mezcla de polvos obtenida es clasificada por tamaños mediante la técnica de tamizado. La fracción de polvos mayoritaria debe tener un rango de tamaño entre1.00 y 0,30 mm.The powder obtained is subsequently ground                 (intermediate mill type - rotary disc cutter).                 The powder mixture obtained is classified by                 sizes by sieving technique. The fraction of                 Majority powders should have a size range                 between 1.00 and 0.30 mm.
Estas etapas permiten la obtención de colágeno tipo I, con las características deseadas. Partiendo de este colágeno se establecieron los protocolos preferidos para desarrollar los soportes de colágeno:These stages allow to obtain collagen                 Type I, with the desired characteristics. Starting from                 this collagen preferred protocols were established                 To develop collagen supports:
Soportes multidireccionales de colágenoMultidirectional Collagen Supports
Obtener suspensión del colágeno tipo I en ácido acético 0,05 M de la proporción deseadaGet suspension of type I collagen in                 0.05 M acetic acid of the desired ratio
Servir en moldes de teflónServe in Teflon Molds
Desgasificar la suspensión mediante vacío de 6,666 kPa hasta evidenciar cese de burbujeoDegassing the suspension by vacuum of                 6,666 kPa until evidencing cessation of bubbling
CongelarFreeze
LiofilizarFreeze dry
Sumergir el material liofilizado en una solución acuosa de glutaraldehidoDip the lyophilized material in a                 aqueous glutaraldehyde solution
Desgasificar el sistema mediante vacíoDegassing the system by vacuum
Dejar en reposo por 24horasLet stand for 24 hours
Retirar la solución de glutaraldehidoRemove the glutaraldehyde solution
Lavar con agua purificadaWash with purified water
Congelar el soporte entrecruzadoFreeze crosslinked support
LiofilizarFreeze dry
EsterilizarSterilize
Soportes unidireccionales de colágenoUnidirectional Collagen Supports
Preparar una suspensión del colágeno tipo I de la concentración deseada.Prepare a suspension of type I collagen from                 the desired concentration
Servir en moldes de teflónServe in Teflon Molds
Desgasificar la suspensión mediante vacío de 6,666 kPa hasta evidenciar cese de burbujeoDegassing the suspension by vacuum of                 6,666 kPa until evidencing cessation of bubbling
Congelar la suspensión poniendo la pared recubierta con aluminio en contacto con un baño de nitrógeno líquido asegurando un gradiente de temperatura de 40°C a través de la suspensiónFreeze the suspension by putting the wall                 coated with aluminum in contact with a bath                 liquid nitrogen ensuring a temperature gradient                 40 ° C through the suspension
LiofilizarFreeze dry
Retirar la tapa de los moldes y se continúa la liofilización Remove the lid from the molds and continue the                 lyophilization
Sumergir el material liofilizado en una solución acuosa de glutaraldehidoDip the lyophilized material in a                 aqueous glutaraldehyde solution
Desgasificar el sistema mediante vacío de 6,666 kPa hasta evidenciar cese de burbujeoDegassing the system by vacuum                 6,666 kPa until evidencing cessation of bubbling
Dejar en reposo por 24horasLet stand for 24 hours
Retirar la solución de glutaraldehidoRemove the glutaraldehyde solution
Hacer lavados con agua purificadaWash with purified water
Congelar el soporte entrecruzadoFreeze crosslinked support
LiofilizarFreeze dry
EsterilizarSterilize

Claims (4)

  1. Procedimiento para la purificación de colágeno tipo I y soportes unidireccionales o multidireccionales con este material, CARACTERIZADO PORQUE comprende las siguientes etapas: a) Obtención de las fuentes de colágeno (Fascia, tendón); b) Limpiar la fuente de colágeno de tejidos adyacentes que se encuentren adheridos y cortar en trozos que permitan su tratamiento; c) Lavar con agua; d) Desengrasar el material empleando lavando con etanol en concentraciones superiores al 70%; e) Diluir con ácido acético hasta lograr un pH de 2,5 a 3,2, a temperaturas inferiores a 5 °C y agitación permanente; f) Licuar y centrifugar el producto obtenido y recuperar el sobrenadante; g) Adicionar al sobrenadante NaOH hasta lograr un pH entre 4,0 y 4,3 centrifugar y recuperar el pellet obtenido; h) Adicionar al pellet una solución de cloruro de sodio hasta alcanzar una conductividad de entre 50 y 60 mS/cm, agitar por un espacio superior a 50 minutos, centrifugar y recuperar nuevamente el pellet obtenido; i) Realizar sucesivos lavados con agua a temperaturas inferiores a 5 °C y agitación, centrifugar y recuperar el pellet; todo esto se repite hasta lograr una conductividad en el agua de lavado entre 200y 500 mS/cm.Procedure for the purification of type I collagen and unidirectional or multidirectional supports with this material, CHARACTERIZED BECAUSE it comprises the following stages: a) Obtaining the sources of collagen (Fascia, tendon); b) Clean the collagen source of adjacent tissues that are attached and cut into pieces that allow treatment; c) Wash with water; d) Degrease the material using washing with ethanol in concentrations higher than 70%; e) Dilute with acetic acid until a pH of 2.5 to 3.2 is achieved, at temperatures below 5 ° C and permanent agitation; f) Blend and centrifuge the product obtained and recover the supernatant; g) Add the NaOH supernatant until a pH between 4.0 and 4.3 is achieved, centrifuge and recover the pellet obtained; h) Add to the pellet a solution of sodium chloride until reaching a conductivity of between 50 and 60 mS / cm, stir for a space exceeding 50 minutes, centrifuge and recover the obtained pellet again; i) Perform successive water washes at temperatures below 5 ° C and stirring, centrifuge and recover the pellet; All this is repeated until a conductivity in the wash water is achieved between 200 and 500 mS / cm.
  2. Procedimiento para la producción del colágeno tipo I reivindicado en 1 CARACTERIZADO PORQUE comprende las siguientes etapas hasta su pulverizado: a) Cuantificar una suspensión de colágeno (método gravimétrico o HPLC); b) Servir en moldes de teflón una película homogénea de la suspensión de colágeno de un espesor entre 3 y 5 mm; c) Eliminar las burbujas de aire de la película mediante vacio (50-1000 mTorr) por diez minutos; d) Secar por convección forzada de aire a un flujo de aire constante entre 25 y 35 m3/hora y a una temperatura de 55±5 C por 24- 48 horas; e) Retirar y triturar la película formada en un mortero de cerámica (aplicación de una fuerza mecánica); f) Moler el polvo obtenido (tipo molino intermedio - cortador de disco rotatorio), clasificar la mezcla de polvos obtenida por tamaños mediante la técnica de tamizado; la fracción de polvos mayoritaria debe tener una rango de tamaño entre 0,84 y 0,59 mm equivalente a la fracción que pasa por un tamiz estándar número 30 y retenido por un tamiz estándar número 20.Procedure for the production of type I collagen claimed in 1 CHARACTERIZED BECAUSE it comprises the following steps until it is sprayed: a) Quantify a collagen suspension (gravimetric method or HPLC); b) Serve in homogeneous Teflon molds a collagen suspension film of a thickness between 3 and 5 mm; c) Remove air bubbles from the film by vacuum (50-1000 mTorr) for ten minutes; d) Dry by forced air convection at a constant air flow between 25 and 35 m3 / hour and at a temperature of 55 ± 5 C for 24-48 hours; e) Remove and crush the film formed in a ceramic mortar (application of a mechanical force); f) Grind the powder obtained (intermediate mill type - rotary disk cutter), classify the powder mixture obtained by sizes by means of the sieving technique; the majority of the dust fraction must have a size range between 0.84 and 0.59 mm equivalent to the fraction that passes through a standard sieve number 30 and retained by a standard sieve number 20.
  3. Procedimiento para la producción de soportes multidireccionales de colágeno reivindicado en 1 CARACTERIZADO PORQUE comprende las siguientes etapas: a) Obtener suspensión de colágeno tipo I en la concentración deseada en ácido acético, que tengan un pH entre 3,0 y 3,2;b) Colocar en moldes que, opcionalmente, cuenten con paredes químicamente inertes y antiadherentes;c) Desgasificar la suspensión mediante vacío hasta evidenciar cese de burbujeo; d) Cubrir el molde asegurando que en su interior no existan espacios libres;e) Congelar la suspensión hasta que alcance -40°C; f) Liofilizar bajo vacío entre 20 y 48horas; g) Retirar la cubierta de los moldes y continuar la liofilización por otro período de tiempo entre 20 y 28 horas; h) Sumergir el material liofilizado en una solución acuosa con un agente de reticulación; i) Desgasificar el sistema mediante vacío hasta evidenciar cese de burbujeo; j) Dejar en reposo entre 20 y 28 horas; k) Retirar la solución con el agente de reticulación; l) Hacer lavados con agua hasta garantizar el retiro del agente de reticulación; m) Congelar el soporte entrecruzado hasta alcanzar temperatura de -20 a -40°C; n) Liofilizar por un espacio de tiempo entre 20 y 48 horas; o) Obtener soportes de colágeno tipo I multidireccionales.Procedure for the production of multidirectional collagen supports claimed in 1 CHARACTERIZED BECAUSE it comprises the following steps: a) Obtain suspension of type I collagen in the desired concentration in acetic acid, having a pH between 3.0 and 3.2; b) Place in molds that, optionally, have chemically inert and non-stick walls; c) Degassing the suspension by vacuum until evidencing cessation of bubbling; d) Cover the mold ensuring that there are no free spaces inside it; e) Freeze the suspension until it reaches -40 ° C; f) Freeze-dry under vacuum between 20 and 48 hours; g) Remove the cover from the molds and continue lyophilization for another period of time between 20 and 28 hours; h) Immerse the lyophilized material in an aqueous solution with a crosslinking agent; i) Degassing the system by vacuum until evidencing cessation of bubbling; j) Leave at rest between 20 and 28 hours; k) Remove the solution with the crosslinking agent; l) Wash with water until the removal of the crosslinking agent is guaranteed; m) Freeze the crosslinked support until it reaches a temperature of -20 to -40 ° C; n) Freeze-dry for a period of time between 20 and 48 hours; o) Obtain multidirectional type I collagen supports.
  4. Procedimiento para la producción de soportes unidireccionales de colágeno reivindicado en 1 CARACTERIZADO PORQUE comprende las siguientes etapas: a) Realizar una suspensión de colágeno tipo I en la proporción deseada en ácido acético que tengan un pH entre 2,5 y 3,2; b) Colocar en moldes que, opcionalmente, cuenten con paredes químicamente inertes y antiadherentes, una de estas paredes en contacto con aluminio; c) Desgasificar la suspensión mediante vacío hasta evidenciar cese de burbujeo; d) Cubrir el molde asegurando que en su interior no existan espacios libres; e) Congelar la suspensión poniendo en contacto la pared recubierta en aluminio con un baño de nitrógeno, asegurando un gradiente de temperatura de 40°C a través de la suspensión; f) Liofilizar entre 20 y 48 horas; g) Retirar la cubierta de los moldes y continuar la liofilización por otro período de tiempo entre 20 y 28 horas; h) Sumergir el material liofilizado en una solución acuosa con un agente de reticulación; i) Desgasificar el sistema hasta evidenciar cese de burbujeo; j) Dejar en reposo entre 20 y 28 horas; k) Retirar la solución con el agente de reticulación; l) Hacer lavados con agua hasta garantizar el retiro del agente de reticulación; m) Congelar el soporte entrecruzado hasta alcanzar temperatura de -20 a -40°C; n) Liofilizar por un espacio de tiempo entre 20 y 48 horas; o) Obtener soportes de colágeno tipo I unidireccionalesProcedure for the production of unidirectional collagen supports claimed in 1 CHARACTERIZED BECAUSE it comprises the following steps: a) Carry out a suspension of type I collagen in the desired proportion in acetic acid having a pH between 2.5 and 3.2; b) Place in molds that, optionally, have chemically inert and non-stick walls, one of these walls in contact with aluminum; c) Degassing the suspension by vacuum until evidencing cessation of bubbling; d) Cover the mold ensuring that there are no free spaces inside; e) Freeze the suspension by contacting the aluminum-coated wall with a nitrogen bath, ensuring a temperature gradient of 40 ° C through the suspension; f) Lyophilize between 20 and 48 hours; g) Remove the cover from the molds and continue lyophilization for another period of time between 20 and 28 hours; h) Immerse the lyophilized material in an aqueous solution with a crosslinking agent; i) Degassing the system until evidencing cessation of bubbling; j) Leave at rest between 20 and 28 hours; k) Remove the solution with the crosslinking agent; l) Wash with water until the removal of the crosslinking agent is guaranteed; m) Freeze the crosslinked support until it reaches a temperature of -20 to -40 ° C; n) Freeze-dry for a period of time between 20 and 48 hours; o) Obtain unidirectional type I collagen supports
PCT/IB2015/058583 2014-11-06 2015-11-06 Method for preparing type i collagen and for preparing unidirectional and multidirectional scaffolds containing same WO2016071876A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CO14-245779 2014-11-06
CO14245779 2014-11-06

Publications (1)

Publication Number Publication Date
WO2016071876A1 true WO2016071876A1 (en) 2016-05-12

Family

ID=55908677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/058583 WO2016071876A1 (en) 2014-11-06 2015-11-06 Method for preparing type i collagen and for preparing unidirectional and multidirectional scaffolds containing same

Country Status (1)

Country Link
WO (1) WO2016071876A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022131896A1 (en) 2020-12-18 2022-06-23 Top Health, S.A.P.I. De C.V. Method for producing human collagen structures with controlled characteristics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061917A2 (en) * 1981-03-27 1982-10-06 Kureha Kagaku Kogyo Kabushiki Kaisha Collagen fibers for use in medical treatment
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
EP1509546B1 (en) * 2002-05-21 2008-10-08 Colltech Australia LTD. Method for producing collagen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061917A2 (en) * 1981-03-27 1982-10-06 Kureha Kagaku Kogyo Kabushiki Kaisha Collagen fibers for use in medical treatment
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
EP1509546B1 (en) * 2002-05-21 2008-10-08 Colltech Australia LTD. Method for producing collagen

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DAVIDENKO, N. ET AL.: "Biomimetic collagen scaffolds with anisotropic pore architecture.", ACTA BIOMATERIALIA, vol. 8, no. 2, 29 September 2011 (2011-09-29), pages 667 - 676, XP028123828 *
MEYER, M. ET AL.: "Soft Collagen-Gelatine Sponges by Convection Drying", BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, vol. 58, no. 1, 2015, pages 109 - 117, XP055278436, Retrieved from the Internet <URL:http://dx.doi.org/10.1590/S1516-8913201400139> *
MONTERO, P. ET AL.: "Extracting conditions for megrim (Lepidorhombus boscii) skin collagen affect functional properties of the resulting gelatin.", JOURNAL OF FOOD SCIENCE, vol. 65, no. 3, 2000, pages 434 - 438, XP002240705 *
SERRANO, J.: "Estandarizaci?n de un proceso de extracci?n de colágeno a partir de los residuos de fileteo de tilapia (Oreochromis sp) y cachama (Piaractus brachypomus", TESIS DEL DEPARTAMENTO DE INGENIERIA AMBIENTAL, UNIVERSIDAD NACIONAL DE COLOMBIA, 2011, Retrieved from the Internet <URL:http://www.bdigital.unal.edu.co/4880/1/jenifercarolinaserranogaona.2011.pdf> [retrieved on 20160219] *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022131896A1 (en) 2020-12-18 2022-06-23 Top Health, S.A.P.I. De C.V. Method for producing human collagen structures with controlled characteristics

Similar Documents

Publication Publication Date Title
Mwale et al. Biological evaluation of chitosan salts cross-linked to genipin as a cell scaffold for disk tissue engineering
KR101056069B1 (en) Method for producing porous three-dimensional scaffold using animal tissue powder
Nazarov et al. Porous 3-D scaffolds from regenerated silk fibroin
EP2349366B1 (en) Active silk muco-adhesives, silk electrogelation process, and devices
ES2624653T3 (en) Porous tissue scaffolds
US10960106B2 (en) Tissue repair material
Diogo et al. Cell-laden biomimetically mineralized shark-skin-collagen-based 3D printed hydrogels for the engineering of hard tissues
Seong et al. Porous calcium phosphate–collagen composite microspheres for effective growth factor delivery and bone tissue regeneration
Ji et al. Chitosan/nHAC/PLGA microsphere vehicle for sustained release of rhBMP‐2 and its derived synthetic oligopeptide for bone regeneration
Kim et al. Angiogenic effects of collagen/mesoporous nanoparticle composite scaffold delivering VEGF 165
CN116966345A (en) 3D printable biogel and method of use thereof
Garske et al. Alginate hydrogels for in vivo bone regeneration: the immune competence of the animal model matters
ES2948984T3 (en) tissue scaffold
EP2826494B1 (en) Method for producing tissue repair material
Li et al. Repair of rat cranial bone defect by using bone morphogenetic protein-2-related peptide combined with microspheres composed of polylactic acid/polyglycolic acid copolymer and chitosan
WO2016071876A1 (en) Method for preparing type i collagen and for preparing unidirectional and multidirectional scaffolds containing same
Lee et al. Preparation of porous collagen/hyaluronic acid hybrid scaffolds for biomimetic functionalization through biochemical binding affinity
CN111050815B (en) Angiogenesis agent and method for producing same
Waheed et al. Cell encapsulation
JP6018477B2 (en) Artificial bone-cartilage complex and method for producing the same
US20200282107A1 (en) Sterile clear concentrated solution of biocompatible collagen, process for the preparation and use thereof
Fan et al. Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitin-hyaluronate scaffold containing microspheres loaded with TGF-β1
ES2961354T3 (en) Injectable collagen suspensions, their preparation procedure and their uses, in particular to form dense collagen matrices
CN111344393A (en) Method for producing insulin-producing cell from mesenchymal stem cell, insulin-producing cell, cell construct, and pharmaceutical composition
JP6906713B2 (en) Pearl farming material, enucleation method and pearl farming material composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15858063

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15858063

Country of ref document: EP

Kind code of ref document: A1